CRC
IBB icon

Curi RMB Capital’s iShares Biotechnology ETF IBB Stock Holding History

Curi RMB Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,452
Closed -$544K – 520
2023
Q3 		$544K Hold
4,452
– – 0.02% 360
2023
Q2 		$565K Sell
4,452
-89
-2% -$11.6K 0.02% 360
2023
Q1 		$587K Buy
+4,541
New +$594K 0.02% 348
2021
Q1 		– Sell
-3,205
Closed -$486K – 503
2020
Q4 		$486K Buy
+3,205
New +$458K 0.02% 431
2020
Q3 		– Sell
-2,806
Closed -$384K – 629
2020
Q2 		$384K Buy
2,806
+300
+12% +$38.2K 0.02% 446
2020
Q1 		$270K Hold
2,506
– – 0.01% 511
2019
Q4 		$302K Sell
2,506
-808
-24% -$90.1K 0.01% 547
2019
Q3 		$330K Sell
3,314
-1,226
-27% -$128K 0.01% 556
2019
Q2 		$495K Sell
4,540
-450
-9% -$47.9K 0.01% 547
2019
Q1 		$558K Buy
4,990
+400
+9% +$43.9K 0.01% 548
2018
Q4 		$443K Sell
4,590
-13,389
-74% -$1.42M 0.01% 674
2018
Q3 		$2.19M Buy
17,979
+1,505
+9% +$177K 0.05% 365
2018
Q2 		$1.81M Sell
16,474
-38,245
-70% -$4.09M 0.04% 399
2018
Q1 		$5.84M Buy
54,719
+4,076
+8% +$452K 0.15% 190
2017
Q4 		$5.41M Buy
50,643
+1,392
+3% +$149K 0.14% 207
2017
Q3 		$5.48M Sell
49,251
-9,021
-15% -$964K 0.14% 214
2017
Q2 		$6.02M Buy
58,272
+10,032
+21% +$988K 0.17% 183
2017
Q1 		$4.72M Sell
48,240
-13,380
-22% -$1.28M 0.2% 139
2016
Q4 		$5.45M Buy
+61,620
New +$5.61M 0.29% 110
2016
Q3 		– Sell
-9,231
Closed -$792K – 468
2016
Q2 		$792K Buy
+9,231
New +$828K 0.04% 262

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Curi RMB Capital's IBB Position: Q4 2023 in Review

Curi RMB Capital sold out of iShares Biotechnology ETF (IBB) in Q4 2023, closing a stake of 4,452 shares — an estimated $544K sold.

Curi RMB Capital first reported a position in IBB in Q2 2016 and held it in 20 quarters. The position peaked at $6.02M in Q2 2017. 872 funds tracked by Wall St. Rank hold IBB as of Q4 2023.

  • Curi RMB Capital reported no remaining iShares Biotechnology ETF position as of Q4 2023 after selling out during the quarter.
  • Curi RMB Capital sold 4,452 iShares Biotechnology ETF shares in Q4 2023, an estimated $544K.
  • Curi RMB Capital first reported a position in iShares Biotechnology ETF in Q2 2016 and held it in 20 quarters.
  • Curi RMB Capital's iShares Biotechnology ETF position peaked at $6.02M in Q2 2017.
  • 872 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2023.

Based on Curi RMB Capital's 13F filing for Q4 2023, filed 14 Feb 2024.